{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:25:41Z","timestamp":1777771541538,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010279","name":"Interleukin Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.cyto.2020.155334","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T20:03:31Z","timestamp":1603915411000},"page":"155334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease"],"prefix":"10.1016","volume":"137","author":[{"given":"Dennis M.","family":"de Graaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph J.A.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-914X","authenticated-orcid":false,"given":"Sanne P.","family":"Smeekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elan","family":"Eisenmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina S.","family":"Redzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique M.","family":"Helsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas E.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassili","family":"Kalabokis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Gresnigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-9830","authenticated-orcid":false,"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.cyto.2020.155334_b0005","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","article-title":"Cloning and characterization of IL-1HY2, a novel interleukin-1 family member","volume":"276","author":"Lin","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cyto.2020.155334_b0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/107999001753289505","article-title":"Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14","volume":"21","author":"Bensen","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.155334_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.cyto.2020.155334_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155334_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2018.01.001","article-title":"The enigmatic role of IL-38 in inflammatory diseases","volume":"39","author":"Garraud","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"49","key":"10.1016\/j.cyto.2020.155334_b0030","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cyto.2020.155334_b0035","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"10.1016\/j.cyto.2020.155334_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2013.00167","article-title":"New insights in the immunobiology of IL-1 family members","volume":"4","author":"van de Veerdonk","year":"2013","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155334_b0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","volume":"8","author":"Mora","year":"2016","journal-title":"J. Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155334_b0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.celrep.2019.03.082","article-title":"IL-38 ameliorates skin inflammation and limits IL-17 production from gammadelta T cells","volume":"27","author":"Han","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.cyto.2020.155334_b0055","first-page":"386","article-title":"IL-38: a new factor in rheumatoid arthritis","volume":"4","author":"Takenaka","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"issue":"2","key":"10.1016\/j.cyto.2020.155334_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2020.155334_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","article-title":"Plasma interleukin-38 in patients with rheumatoid arthritis","volume":"65","author":"Xu","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0070","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.21928","article-title":"Association between the interleukin-1 family gene cluster and psoriatic arthritis","volume":"54","author":"Rahman","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.cyto.2020.155334_b0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","article-title":"IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment","volume":"9","author":"Mercurio","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.cyto.2020.155334_b0080","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/art.39328","article-title":"Brief report: interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus","volume":"67","author":"Rudloff","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0085","doi-asserted-by":"crossref","first-page":"E933","DOI":"10.3390\/molecules21070933","article-title":"Aberrant expression of novel cytokine IL-38 and regulatory T lymphocytes in childhood asthma","volume":"21","author":"Chu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.cyto.2020.155334_b0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.intimp.2016.09.023","article-title":"IL-38 alleviates concanavalin A-induced liver injury in mice","volume":"40","author":"Yuan","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2020.155334_b0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12612","article-title":"Biology of IL-38 and its role in disease","volume":"281","author":"van de Veerdonk","year":"2018","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.cyto.2020.155334_b0105","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1073\/pnas.0308680101","article-title":"Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family","volume":"101","author":"Garlanda","year":"2004","journal-title":"Proc. Natl. Acad Sci. USA"},{"issue":"6","key":"10.1016\/j.cyto.2020.155334_b0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1beta and by the induction of endogenous IL-1Ra","volume":"75","author":"Joosten","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"13","key":"10.1016\/j.cyto.2020.155334_b0115","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1158\/0008-5472.CAN-07-0560","article-title":"Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family","volume":"67","author":"Garlanda","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2020.155334_b0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12609","article-title":"Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8","volume":"281","author":"Molgora","year":"2018","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cyto.2020.155334_b0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155334_b0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2013.00180","article-title":"Decoys and regulatory \u201creceptors\u201d of the IL-1\/toll-like receptor superfamily","volume":"4","author":"Garlanda","year":"2013","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155334_b0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nold-Petry","year":"2015","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155334_b0140","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1471-4159.2008.05304.x","article-title":"IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR\/TIR8","volume":"105","author":"Costelloe","year":"2008","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.cyto.2020.155334_b0145","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/rheumatology\/kew325","article-title":"Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation","volume":"55","author":"Cavalli","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.cyto.2020.155334_b0150","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad Sci. USA"},{"issue":"2","key":"10.1016\/j.cyto.2020.155334_b0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"10.1016\/j.cyto.2020.155334_b0160","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1097\/MJT.0000000000000524","article-title":"Effectiveness of anakinra in acute gout: a retrospective review of initial and refractory therapy","volume":"24","author":"Petite","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.cyto.2020.155334_b0165","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/key402","article-title":"Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial","author":"Janssen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3899\/jrheum.180393","article-title":"Utility of anakinra in acute crystalline diseases: a retrospective study comparing a university hospital with a veterans affairs medical center","volume":"46","author":"Desmarais","year":"2019","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155334_b0175","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-014-2601-7","article-title":"Anakinra treatment in patients with gout and type 2 diabetes","volume":"34","author":"Vitale","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155334_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.cyto.2020.155334_b0185","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.cyto.2020.155334_b0190","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.cyto.2020.155334_b0195","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.cyto.2020.155334_b0200","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155334_b0205","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1819672116","article-title":"Interleukin-37 monomer is the active form for reducing innate immunity","volume":"116","author":"Eisenmesser","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cyto.2020.155334_b0210","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/jcmm.14902","article-title":"Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+CD25+ regulatory T cells","volume":"24","author":"Ge","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2020.155334_b0215","doi-asserted-by":"crossref","first-page":"A38","DOI":"10.1136\/annrheumdis-2018-EWRR2018.79","article-title":"IL-38 in arthritis maturation and degradation of this new IL-1 family anti-inflammatory cytokine","volume":"77","author":"Harel","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2020.155334_b0220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41423-019-0300-7","article-title":"Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma","volume":"17","author":"Sun","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cyto.2020.155334_b0225","doi-asserted-by":"crossref","first-page":"154963","DOI":"10.1016\/j.cyto.2019.154963","article-title":"Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation","volume":"127","author":"Xie","year":"2020","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0230","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/annrheumdis-2016-210630","article-title":"IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro","volume":"76","author":"Boutet","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"24","key":"10.1016\/j.cyto.2020.155334_b0235","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/ajmg.a.32613","article-title":"Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family","volume":"146a","author":"Nawara","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.cyto.2020.155334_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2008.03.084","article-title":"A study on the correlation between IL1RAPL1 and human cognitive ability","volume":"438","author":"Gao","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"30","key":"10.1016\/j.cyto.2020.155334_b0245","doi-asserted-by":"crossref","first-page":"31664","DOI":"10.1074\/jbc.M403434200","article-title":"Crystal structure of the Toll\/interleukin-1 receptor domain of human IL-1RAPL","volume":"279","author":"Khan","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cyto.2020.155334_b0250","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/infdis\/jiy289","article-title":"Interleukin 38 protects against lethal sepsis","volume":"218","author":"Xu","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2020.155334_b0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/cyto.2002.0873","article-title":"Interleukin-1F7B (IL-1H4\/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production","volume":"18","author":"Kumar","year":"2002","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cyto.2020.155334_b0260","doi-asserted-by":"crossref","first-page":"eaaj1548","DOI":"10.1126\/sciimmunol.aaj1548","article-title":"Homodimerization attenuates the anti-inflammatory activity of interleukin-37","volume":"2","author":"Ellisdon","year":"2017","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155334_b0265","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2016.10.012","article-title":"In vivo anti-inflammatory activities of novel cytokine IL-38 in murphy roths large (MRL)\/lpr mice","volume":"222","author":"Chu","year":"2017","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.cyto.2020.155334_b0270","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcmm.14741","article-title":"Interleukin-38 alleviates cardiac remodelling after myocardial infarction","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell Mol. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:36Z","timestamp":1760907576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620303501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"alternative-id":["S1043466620303501"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155334","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155334"}}